Iron and menstrual blood loss

What a study of ferrous sulfate and menstrual blood loss showed.

Key points

  • In female students without anemia, the menstrual blood-loss score after three cycles of ferrous sulfate did not differ clearly from placebo. A confirmed reduction in this measure from the supplement was not shown. [1] See the evidence 1
  • Menstruation alone does not establish iron deficiency. Before choosing a supplement, discuss individual measures with a professional. [2] [3] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

Menstrual blood loss and iron stores are different questions.

Key points

Why these conclusions

Study result

Female students without anemia took 50 mg elemental iron as sulfate on the first four days of each of three cycles or placebo. The Higham score in the fourth cycle did not differ clearly; these are scale points, not measured milliliters. Certainty is very low. [1]

Menstruation, pregnancy, diet and age change the likelihood of low iron stores, but do not by themselves establish deficiency. The fatigue study result in women with ferritin <50 µg/L cannot be applied to people with normal iron stores. Ferritin below 50 µg/L was a study eligibility condition, not a universal deficiency threshold; ferritin may rise during inflammation. [2] [3]

In hereditary hemochromatosis iron can accumulate in the body. Iron supplements should be avoided with this condition; general intake limits are not permission to take them. EFSA established a safe level of total intake of 40 mg/day from all sources for adults, including pregnant and breastfeeding women, not a formal UL; the US UL for healthy adults is 45 mg/day from food and supplements. A doctor may prescribe a higher dose when indicated. [4] [2]

After three cycles of ferrous sulfate, the Higham menstrual blood-loss score did not differ clearly from placebo. These are scale points, not measured milliliters.

ParameterData
ResultAfter three cycles of ferrous sulfate, the Higham menstrual blood-loss score did not differ clearly from placebo. These are scale points, not measured milliliters. In the fourth cycle: 69.90 ± 52.08 points with iron versus 64.25 ± 50.81 with placebo; p=0.527. Group-by-time interaction: p=0.916.
Participants160 female students without anemia were assigned to groups; 73 on iron and 62 on placebo were analyzed
FormOral ferrous sulfate
Dose50 mg elemental iron daily on the first four days of each cycle
Dose basis50 mg elemental iron daily on the first four days of each cycle
ComparatorPlacebo
DurationThree cycles of intake; outcome in the fourth cycle
Confidence1/4: Precision: Small sample or substantial uncertainty of the confidence interval; Consistency: One comparison or heterogeneity cannot be assessed.; Applicability: The result was measured directly in the specified group.; Possible publication bias: No specific data; it cannot be excluded.; Study methods: Complete-data analysis excluded 7 of 80 participants in the iron group and 18 of 80 in the placebo group; differences in missing data cast doubt on the between-group estimate.
Evidence base1 trial
Sources[1]

Menstruation, pregnancy, diet and age change the likelihood of low iron stores, but do not by themselves establish deficiency. The fatigue study result in women with ferritin <50 µg/L cannot be applied to people with normal iron stores. Ferritin below 50 µg/L was a study eligibility condition, not a universal deficiency threshold; ferritin may rise during inflammation.

Menstruation, pregnancy, diet and age change the likelihood of low iron stores, but do not by themselves establish deficiency. The fatigue study result in women with ferritin <50 µg/L cannot be applied to people with normal iron stores. Ferritin below 50 µg/L was a study eligibility condition, not a universal deficiency threshold; ferritin may rise during inflammation. [2] [3]

In hereditary hemochromatosis iron can accumulate in the body. Iron supplements should be avoided with this condition; general intake limits are not permission to take them. EFSA established a safe level of total intake of 40 mg/day from all sources for adults, including pregnant and breastfeeding women, not a formal UL; the US UL for healthy adults is 45 mg/day from food and supplements. A doctor may prescribe a higher dose when indicated.

In hereditary hemochromatosis iron can accumulate in the body. Iron supplements should be avoided with this condition; general intake limits are not permission to take them. EFSA established a safe level of total intake of 40 mg/day from all sources for adults, including pregnant and breastfeeding women, not a formal UL; the US UL for healthy adults is 45 mg/day from food and supplements. A doctor may prescribe a higher dose when indicated. [4] [2]

More details

How to assess iron stores

Menstruation can change the likelihood of low stores, but does not by itself establish deficiency. [2]

Sources

  1. The effect of iron supplementation on menstrual bleeding volume and hemoglobin level during menstrual bleeding: A randomized clinical trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC10965019/
  2. Iron - Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
  3. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC3414597/
  4. Scientific opinion on the tolerable upper intake level for iron. https://www.efsa.europa.eu/en/plain-language-summary/scientific-opinion-tolerable-upper-intake-level-iron

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Iron